Related Experiment Videos
Pseudomonas peritonitis in peritoneal dialysis patients: the Network #9 Peritonitis Study
M Bunke1, M E Brier, T A Golper
1Division of Nephrology, University of Arkansas for Medical Sciences, Little Rock 72205-7199, USA.
Summary
Pseudomonas peritonitis (PsP) in peritoneal dialysis patients is linked to immunosuppressive agents and has worse outcomes than non-Pseudomonas infections. Risk factors for PsP were not identified, and resolution rates were low.
Area of Science:
- Nephrology
- Infectious Diseases
- Peritoneal Dialysis
Background:
- Peritonitis is a serious complication in peritoneal dialysis (PD).
- Pseudomonas peritonitis (PsP) may have distinct risk factors and outcomes compared to other bacterial peritonitis.
- Understanding PsP is crucial for optimizing PD patient care and infection management.
Purpose of the Study:
- To identify risk factors for Pseudomonas peritonitis (PsP) in PD patients.
- To compare outcomes of PsP with non-Pseudomonas bacterial peritonitis (non-PsP).
- To analyze factors associated with PsP resolution versus treatment failure.
Main Methods:
- Prospective study comparing PD patients with PsP to those with non-PsP.
- Data from the Tristate Renal Network Peritonitis and Catheter Survival Study.
- Outcomes included resolution, catheter removal, switch to hemodialysis, or death.
Main Results:
- No demographic differences (race, gender, age, diabetes) between PsP and non-PsP groups.
- PsP group showed higher incidence of prior immunosuppressive agent exposure (25% vs 10.6%, P=0.028).
- PsP associated with exit/tunnel infections, higher hospitalization, catheter loss, hemodialysis switch, and poorer resolution rates (P < 0.05).
Conclusions:
- Previous immunosuppressive agent exposure may be a risk factor for PsP.
- PsP is associated with more severe complications and lower resolution rates than non-PsP.
- Logistic regression did not identify specific patient risk factors for developing PsP.